Urinary Stress Incontinence Clinical Trial
Official title:
Biomechanical Effects of Duloxetine on Bladder Function and Sphincter Resistance During the Emptying Phase and on Urethral Function During the Filling Phase of the Micturition Cycle in Women With Pure Genuine Stress Incontinence
Verified date | January 2007 |
Source | Eli Lilly and Company |
Contact | n/a |
Is FDA regulated | No |
Health authority | United States: Food and Drug Administration |
Study type | Interventional |
Double-blind placebo-controlled study of the biomechanical effects of duloxetine compared with placebo in the treatment of women with pure genuine stress incontinence
Status | Completed |
Enrollment | 50 |
Est. completion date | April 2006 |
Est. primary completion date | |
Accepts healthy volunteers | No |
Gender | Female |
Age group | 18 Years to 75 Years |
Eligibility |
Inclusion Criteria: - Female - Between 18 and 75 years of age - Diagnosis of GSI - Have discrete episodes of incontinence Exclusion Criteria: - Positive urine culture at visit 1 - Use of MAOI - Have had continence or urethral surgery - Use of anti-incontinence device, vaginal pessaries or medications for the treatment of urinary incontinence - Began pelvic floor muscle exercises within 6 months prior to study entry. |
Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double-Blind, Primary Purpose: Treatment
Country | Name | City | State |
---|---|---|---|
United States | For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Monday - Friday from 9:00 AM to 5:00 PM Eastern Time (UTC/GMT - 5hours, EST), or speak with your personal physician | Indianapolis | Indiana |
Lead Sponsor | Collaborator |
---|---|
Eli Lilly and Company | Boehringer Ingelheim |
United States,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Compare the effects of duloxetine with placebo in women with urodynamically proved genuine stress incontinence(GSI)on vesical Valsalva leak point pressure | |||
Secondary | Compare the effects of duloxetine with that of placebo on measures of bladder emptying phase function derived from | |||
Secondary | non-instrumented and instrumented uroflowmetry studies | |||
Secondary | Percent change in Incontinent Episode Frequency (IEF) from baseline to endpoint | |||
Secondary | Subject-perceived improvement in their GSI as measured by the Patient Global Impressions-Improvement (PGI-I) questionnaire at endpoint | |||
Secondary | Compare duloxetine responders with duloxetine non-responders with respect to: | |||
Secondary | Baseline measures of urethral function | |||
Secondary | Outcome measures of urethral function | |||
Secondary | Outcome measures of emptying function | |||
Secondary | Vital signs, laboratory values and the occurrence of treatment-emergent adverse events | |||
Secondary | In the open-label extension: | |||
Secondary | Determine the effects of duloxetine six to seven months after initiation on measures of urethral function | |||
Secondary | Collect long-term data on the maintenance of effect of duloxetine in the treatment of GSI as measured by IEF, PGI-I, vital signs, laboratory values and the occurrence of treatment-emergent adverse events. |
Status | Clinical Trial | Phase | |
---|---|---|---|
Active, not recruiting |
NCT02867748 -
TVT-ABBREVO Versus SERASIS for the Treatment of Female Urinary Stress Incontinence: 1 Year Outcomes of a Comparative Study With 2 Trans-obturator Sub Mid Urethral Slings
|
N/A | |
Recruiting |
NCT02617797 -
Radiofrequency in the Female Stress Urinary Incontinence
|
N/A | |
Active, not recruiting |
NCT02538991 -
TVT Versus Bulkamid®-Injections in Treatment of Stress Urinary Incontinence
|
N/A | |
Completed |
NCT02480231 -
Mid-Urethral Sling Tensioning Trial
|
N/A | |
Terminated |
NCT02591381 -
Transcorporal Versus Standard Artificial Urinary Sphincter Placement
|
N/A | |
Completed |
NCT00984958 -
Bulkamid Treatment of Stress Incontinence in Women With Urinary Stress Incontinence and Not Suitable to TVT-procedure
|
N/A | |
Completed |
NCT02423486 -
The Comparison of Efficacy Between Electromagnetic Stimulation Therapy and Electromagnetic Stimulation Therapy With Extracorporeal Biofeedback
|
N/A | |
Completed |
NCT01754558 -
One Year Outcome Using the Ajust System for Treatment of Urinary Stress Incontinence
|
N/A | |
Recruiting |
NCT00136071 -
Transvaginal Tension Free Vaginal Tape-Obturator (TVT-O) Versus Transobturator Tape-Mentor (TOT) in the Management of Urodynamic Stress Urinary Incontinence
|
N/A | |
Completed |
NCT00190619 -
Efficacy and Safety of Duloxetine
|
Phase 3 | |
Completed |
NCT04288648 -
Pelvic Floor Contraction in Different Positions Among Women With and Without Stress Urinary Incontinence
|
||
Active, not recruiting |
NCT05182632 -
Tele-rehabilitation Group Program for Urinary Incontinence in Older Women
|
N/A | |
Completed |
NCT03672461 -
A Group-Based Therapeutic Yoga Intervention for Urinary Incontinence in Ambulatory Older Women
|
N/A | |
Completed |
NCT02407145 -
Safety and Efficacy of PVDF (DynaMesh®-SIS Soft) Retropubic Midurethral Slings in Stress Urinary Incontinence in Women
|
||
Completed |
NCT01784172 -
Efficacy and Safety Study of Electroacupuncture for Simple Female Stress Urinary incontinence-a Multicenter Trial
|
Phase 2 | |
Not yet recruiting |
NCT06469320 -
Urinary Incontinence and Other Pelvic Floor Dysfunctions in Trail Runners
|
||
Recruiting |
NCT02935803 -
A Study on the Anti-incontinent Effectiveness of the mTVM Method in POPQ Stage II-III Patients
|
N/A | |
Active, not recruiting |
NCT02039830 -
Group Versus Individual Physiotherapy for Urinary Incontinence in Aging Women
|
N/A | |
Recruiting |
NCT04817839 -
Optimal Duration of Post-Operative Activity Restriction After Midurethral Sling Procedures
|
N/A | |
Completed |
NCT03439527 -
Multisystem Cell Therapy for Improvement of Urinary Continence
|
Phase 1 |